Sudeep Pharma Ltd. (SUDEEPPHRM) Share Price Hits Fresh 52-Week High

Sudeep Pharma Ltd. Share Price hits a fresh 52-week high at Rs 912.65, rising 0.98% today with a market cap of Rs 9,932.7 crore.

Sudeep Pharma Ltd. Share Price reached a fresh 52-week high of Rs 912.65 today, marking a 0.98% increase from the previous close of Rs 879.4. The company, with a market capitalization of Rs 9,932.7 crore, opened at Rs 900 and saw a low of Rs 888.05 during the trading session. This price movement highlights investor interest in Sudeep Pharma Ltd., as it navigates the healthcare sector landscape.

Sudeep Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 888.05
Previous Close	Rs 879.4
Today's Change	+Rs 8.65 (+0.98%)
Day Open	Rs 900
Fresh 52-Week High	Rs 912.65
Day Low	Rs 888.05
Current Volume	6,475
Turnover	Rs 0.58 crore
Market Capitalisation	Rs 9,932.7 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 888.05. versus the previous close of Rs 879.4, a rise of 0.98%. The stock opened at Rs 900, reached Rs 912.65, touched Rs 888.05. Reported volume was 6,475.

Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 888.05 versus the previous close of Rs 879.4, a rise of 0.98%. The stock opened at Rs 900, reached Rs 912.65, and touched Rs 888.05. Reported volume was 6,475.

Today, Sudeep Pharma Ltd. Share Price opened at Rs 900 and climbed to a fresh 52-week high of Rs 912.65. The stock closed at Rs 888.05, reflecting a day change of Rs 8.65 or 0.98%. The trading volume stood at 6,475 shares, with a turnover of Rs 0.58 crore. This price action indicates a positive sentiment among investors, as the stock broke its previous 52-week high.

Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 9,932.7 crore
P/E Ratio	30.09x
P/B Ratio	0.44x
ROE	-2.89%
ROCE	-0.26%

Sudeep Pharma Ltd. was valued at a P/E ratio of 30.09x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	30.09x
Benchmark Median P/E	20.73x
Benchmark Average P/E	67.98x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	0.44x
Benchmark Median P/B	1.91x
Company ROE	-2.89%
Benchmark Median ROE	10.7%
Company ROCE	-0.26%
Benchmark Median ROCE	13.13%
Company Market Capitalisation	Rs 9,932.7 crore
Benchmark Median Market Cap	Rs 130.49 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 30.09x, which is above the benchmark median of 20.73x, a difference of +45.15%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of -2.89%, which is below the benchmark median of 10.7%, a difference of -127.01%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of -0.26%, which is below the benchmark median of 13.13%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,931.84	30.09	0.44	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,683.28	39.84	8.11	28.21	26.35
Beta Drugs Ltd.	BETA	2,474.26	59.65	7.97	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,416.82	169.49	3.13	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,414	34.44	6.97	-2.6	16.92

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 30.09x compared with the displayed peer median of 39.84x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 9,932.7 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Sudeep Pharma Ltd.

• Fresh 52-week high at Rs 912.65, indicating positive investor sentiment.
• Higher market cap compared to sector median, showcasing significant market presence.
• Mixed valuation with a P/E ratio above sector median but below average.
• Negative profitability metrics, highlighting areas for operational improvement.

About Sudeep Pharma Ltd.

Sudeep Pharma Ltd. operates in the healthcare sector, focusing on pharmaceutical products. The company is known for its diverse range of healthcare solutions, catering to various medical needs. Its substantial market capitalization reflects its strong position within the industry, despite challenges in profitability and capital efficiency.

Track Sudeep Pharma Ltd. Share Price on Univest

Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Sudeep Pharma Ltd. Share Price, technical indicators, fundamental ratios, shareholding patterns, and market insights on Univest for comprehensive analysis and informed decision-making.

Frequently Asked Questions

What is the current share price of Sudeep Pharma Ltd.?

Ans. The current share price of Sudeep Pharma Ltd. is Rs 888.05, following a 0.98% increase today. The stock moved 0.98% during the session. The intraday range extended from Rs 888.05 to Rs 912.65.

What is the market capitalization of Sudeep Pharma Ltd.?

Ans. Sudeep Pharma Ltd. has a market capitalization of Rs 9,932.7 crore, reflecting its significant presence in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 30.09x.

How does Sudeep Pharma Ltd.'s P/E ratio compare to the sector?

Ans. Sudeep Pharma Ltd.'s P/E ratio of 30.09 is above the sector median of 20.73 but below the average of 67.98, indicating a mixed valuation. The company trades at a P/E ratio of 30.09x.

What are the profitability metrics of Sudeep Pharma Ltd.?

Ans. Sudeep Pharma Ltd. has a negative ROE of -2.89% and ROCE of -0.26%, highlighting challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.7%.

What is the 52-week high of Sudeep Pharma Ltd.?

Ans. Sudeep Pharma Ltd. reached a fresh 52-week high of Rs 912.65 today, indicating strong investor interest. The stock moved 0.98% during the session. The intraday range extended from Rs 888.05 to Rs 912.65.

How does Sudeep Pharma Ltd. compare to its peers?

Ans. Sudeep Pharma Ltd. has a similar P/E ratio to peers but lags in profitability metrics like ROE and ROCE. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.

What is the P/B ratio of Sudeep Pharma Ltd.?

Ans. The P/B ratio of Sudeep Pharma Ltd. is 0.44, significantly lower than the sector median of 1.91. The company trades at a P/E ratio of 30.09x. Its P/B ratio is 0.44x.